Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 1.00 |
| ▸ | LTA4H | P09960 | 5/20 | 0.85 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | PLA2G4B | P0C869 | 4/20 | 0.61 |
| ▸ | RARB | P10826 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337960 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL2675357 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1837360 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL337505 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL337790 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1834632 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL1835315 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL4238973 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL21054750 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B | |
| SCHEMBL57745 | 1.00 | NR5A1 (1.00) | NR5A1LTA4HTP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 489 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117110493-A | Metabolic marker associated with neonatal pneumonia and metabolic acidosis and application thereof | 大连大学 | 2023-11-24 | — | — | CN | claimed |
| CN-116893237-A | Metabolic marker related to neonatal pneumonia and myocardial damage and application thereof | 大连大学 | 2023-10-17 | — | — | CN | claimed |
| CN-113265270-B | Boiling bed residual oil hydrogenation process and boiling bed residual oil hydrogenation device | 中国石油化工股份有限公司 | 2023-03-10 | — | — | CN | claimed |
| US-11479628-B2 | Shelf stable, low tin concentration, dual cure additive manufacturing resins | CARBON, INC. (US) | 2022-10-25 | — | — | US | claimed |
| CN-113265270-A | Boiling bed residual oil hydrogenation process and boiling bed residual oil hydrogenation device | 中国石油化工股份有限公司 | 2021-08-17 | — | — | CN | claimed |
| US-9796693-B2 | Method for prevention of premature polymerization | NITTO EUROPE N.V. (BE) | 2017-10-24 | — | — | US | claimed |
| US-20160280673-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | NITTO EUROPE N.V. (BE) | 2016-09-29 | — | — | US | claimed |
| EP-3072879-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | NITTO EUROPE N.V (BE) | 2016-09-28 | — | — | EP | claimed |
| EP-3053992-A1 | Biodiesel | LANXESS Deutschland GmbH (DE) | 2016-08-10 | — | — | EP | claimed |
| US-7560205-B2 | Photoconductive imaging members | XEROX CORPORATION (US) | 2009-07-14 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-20050208416-A1 | Branched polyarylene ethers and processes for the preparation thereof | XEROX CORPORATION | 2005-09-22 | — | — | US | claimed |
| US-20050154178-A1 | Process for preparing branched polyarylene ethers | XEROX CORPORATION | 2005-07-14 | — | — | US | claimed |
| US-6500982-B1 | DEHYDRATION IN PRESENCE OF POLYMERIZATION INHIBITOR WITH TURNDOWN CONTROL, I.E. ADJUSTING WATER OR ORGANIC SOLVENT FED TO MAINTAIN OPTIMAL DISTILLATION COLUMN PERFORMANCE | ROHM AND HAAS COMPANY | 2002-12-31 | — | — | US | claimed |
| EP-1065197-B1 | Process for preparing (meth)acrylic acid | ROHM & HAAS (US) | 2002-11-06 | — | — | EP | claimed |
| EP-1065197-A1 | Process for preparing (meth)acrylic acid | ROHM AND HAAS COMPANY (US) | 2001-01-03 | — | — | EP | claimed |
| US-5728872-A | POLYMERIZATION INHIBITION WITH A NITROXYL RADICAL AND A DIHETERO-SUBSTITUTED BENZENE COMPOUND HAVING AT LEAST ONE TRANSFERABLE HYDROGEN | ECOLAB USA INC. | 1998-03-17 | — | — | US | claimed |
| EP-0765856-A1 | Stabilized acrylic acid compositions | Riemenschneider, Lutz (DE) | 1997-04-02 | — | — | EP | claimed |
| US-4929530-A | OXIDATIVE LEUCO DYES, PHOTO-OXIDIZERS, REDUCING AGENTS, ORGANIC SULFONAMIDES AND PHENOLIC COMPONENTS; EXPOSING TO LIGHT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280673-A1 | METHOD FOR PREVENTION OF PREMATURE POLYMERIZATION | PGF, TTPA, MLN | NR5A1 3685/4885LTA4H 245/4885TP53 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.